中文 | EN | 日本語
Financial Reports Latest Updates Industry Maps Economic Calendar

Schrodinger, Inc. (SDGR) Annual Reports

Schrodinger, Inc. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

  • Exchange: Nasdaq
  • Fiscal year end: 12/31
  • SEC CIK: 1490978 →

Website:Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
CurrentPrior yearYoY
Revenue $58.9M $54.8M +7.5%
Operating income $-41.5M $-52.9M +21.5%
Net income $6.0M $-43.2M +113.8%
EPS (diluted) $0.08 $-0.59 +113.6%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit
Quarterly · In mn (USD)
Revenue 58.9 mn Net income 5.98 mn
2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2
Show table:Income statement
Item2019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Revenue20.7 19.0 20.0 25.8 26.2 23.1 25.8 33.0 32.1 29.8 29.9 46.2 48.7 38.5 37.0 56.8 64.8 35.2 42.6 74.1 36.6 47.3 35.3 88.3 59.5 54.8 54.3 87.2 58.6 58.9
Gross profit13.0 9.85 10.7 15.5 15.6 13.6 15.3 19.0 16.2 12.0 11.1 26.4 28.0 17.1 17.2 38.7 45.7 13.8 23.6 57.5 18.9 31.3 17.7 64.1 31.1 26.2 28.0 57.3 29.6 32.4
Operating income-5.61 -14.0 -11.3 -7.85 -11.8 -17.1 -15.4 -16.6 -23.9 -30.3 -34.7 -22.5 -28.6 -43.5 -46.2 -28.5 -30.5 -61.1 -56.2 -29.6 -67.4 -52.7 -68.4 -20.7 -50.9 -52.9 -46.0 -17.2 -48.8 -41.5
Net income-5.79 -0.5 -11.5 -6.77 -13.8 -3.35 3.85 -11.1 -0.03 -34.6 -35.0 -30.7 -34.4 -47.7 -39.9 -27.2 129 4.28 -62.0 -30.7 -54.7 -54.0 -38.1 -40.2 -59.8 -43.2 -32.8 32.5 -60.0 5.98
Balance sheet
Quarterly · In mn (USD)
Total assets 640 mn Total liabilities 311 mn
2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table:Balance sheet
Item2019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Current assets119 313 307 621 683 675 650 622 625 586 557 524 534 604 592 548 568 494 449 456 635 571 514 472 519 464 470
Total assets155 350 350 680 746 744 717 763 756 720 688 662 689 839 842 794 803 738 688 669 823 743 688 654 726 634 640
Current liabilities45.0 42.2 43.0 39.3 73.2 67.6 70.4 72.9 91.2 85.5 85.6 88.8 109 123 107 105 134 107 99.8 111 192 165 156 145 189 170 174
Total liabilities57.0 54.3 53.4 49.2 122 112 112 183 199 189 195 199 241 249 230 231 254 224 214 220 402 370 345 332 362 321 311
Equity-76.7 -76.5 -87.3 -93.4 296 296 631 624 632 606 580 557 531 493 463 448 590 611 564 549 514 474 449 421 374 343 321 364 314 329
Cash flow
Quarterly · In mn (USD)
Operating -34.1 mn Investing 58.6 mn Financing 0.65 mn
2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

Positive = cash in, negative = cash out.

Show table:Cash flow statement
Item2019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Operating-4.62 -4.24 -5.93 -11.3 -5.78 -9.05 -12.0 43.6 -10.9 -29.4 -10.6 -19.7 -39.7 -24.7 -30.4 -24.9 -31.1 -18.4 -49.9 -37.3 -39.3 -53.7 -33.3 -31.1 144 -52.2 -61.9 -16.1 -14.8 -34.1
Investing-16.1 -38.5 -5.66 6.38 -87.9 -24.6 -216 -53.2 -61.9 14.8 52.4 -22.1 36.3 34.3 7.84 11.6 172 67.2 13.2 -59.6 5.08 29.6 90.7 23.5 30.6 -55.6 11.5 71.4 44.6 58.6
Financing5.17 25.0 0.23 -1.71 212 -0.73 328 1.43 3.66 1.64 1.44 1.22 0.91 0.4 0.32 0.48 0.87 4.52 1.33 2.33 8.01 1.61 0.39 0.12 0.41 2.02 0.31 0.2 0.57 0.65
Cash at period end62.2 44.5 33.1 26.0 145 110 210 202 133 118 161 120 117 127 103 90.5 233 286 249 155 130 108 160 147 326 220 172 231 260 288
Profitability
Quarterly · %
Gross margin 55.1% Operating margin -70.5% Net margin 10.2%
2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

Gross, operating and net margin = the respective profit ÷ revenue.

Show table:Profitability
Item2019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Gross margin62.7%51.8%53.7%60.1%59.7%58.8%59.2%57.5%50.3%40.2%37.2%57.1%57.5%44.5%46.5%68.1%70.5%39.3%55.5%77.6%51.6%66.2%50.2%72.6%52.3%47.8%51.6%65.7%50.4%55.1%
Operating margin-27.1%-73.5%-56.6%-30.4%-45.1%-74.0%-59.9%-50.2%-74.4%-101.9%-116.2%-48.8%-58.9%-113.0%-124.8%-50.2%-47.1%-173.7%-132.0%-40.0%-184.3%-111.4%-193.9%-23.4%-85.5%-96.6%-84.6%-19.7%-83.3%-70.5%
Net margin-27.9%-2.6%-57.7%-26.2%-52.8%-14.5%14.9%-33.7%-0.1%-116.3%-117.3%-66.5%-70.8%-124.0%-107.8%-47.9%199.3%12.2%-145.7%-41.4%-149.5%-114.2%-108.1%-45.5%-100.4%-78.8%-60.4%37.3%-102.5%10.2%
Returns & leverage
Quarterly · %
ROE -16.2% ROA -8.2% Debt ratio 48.6%
2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table:Returns & leverage
Item2019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
ROE-29.8%-32.3%-7.4%-9.2%-2.3%-9.3%-13.3%-17.0%-23.2%-26.9%-29.3%-29.7%2.6%12.0%8.6%8.2%-25.9%-37.1%-35.1%-38.6%-43.3%-44.4%-45.7%-26.3%-30.1%-16.2%
ROA-15.8%-9.3%-10.1%-3.0%-5.4%-1.9%-7.9%-11.2%-13.4%-18.4%-21.0%-21.4%-20.6%1.9%8.7%6.1%5.5%-18.2%-26.3%-24.3%-23.0%-26.0%-26.3%-26.6%-13.3%-15.0%-8.2%
Debt ratio36.7%15.5%15.3%7.2%16.4%15.1%15.6%24.0%26.4%26.3%28.3%30.0%35.0%29.6%27.4%29.0%31.7%30.4%31.1%32.9%48.8%49.7%50.2%50.8%49.9%50.6%48.6%
EPS
Quarterly · US$
EPS US$0.08
2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2
Show table:EPS
Item2019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
EPS(US$)-0.260.05-0.18-0.49-0.49-0.43-0.48-0.67-0.56-0.391.750.06-0.86-0.41-0.76-0.74-0.52-0.55-0.82-0.59-0.450.44-0.810.08

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Schrodinger, Inc. (SDGR) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.